Key facts
- Airfinity’s last known valuation is $69.4M (Oct 2022).
- It has raised $12.6M; the latest was Later Stage VC in Oct 2025.
- Notable investors include In-Q-Tel, The FSE Group, British Business Bank, Gresham House Asset Management, Baronsmead — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Airfinity
- ·The full record, as it builds
Funding rounds
No funding rounds for Airfinity are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Airfinity
Developer of a health technology platform designed to provide global health intelligence and analytics. The company's platform offers proprietary surveillance tools and forecast models with analysis for dozens of infectious diseases, including COVID, influenza, and respiratory syncytial virus (RSV), enabling pharmaceuticals, governments, and investors to understand and make decisions rapidly to save lives.
- Sector
- Healthcare
- HQ
- London, United Kingdom
- Founded
- 2015
- Employees
- 77
- Website
- airfinity.com/
- Ownership
- Privately Held (backing)
Airfinity doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Airfinity shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Airfinity in its N-PORT filings yet. We sweep new filings monthly.